Tue, Aug 06, 2024
Lupin Q1 FY25 Results Preview: Mumbai-headquartered drug maker Lupin is estimated to register a 30 per cent year-on-year jump in its consolidated net profit for the April-June period. Read on to know what else you can expect in the pharmaceutical company's upcoming earnings report.
More >
Mon, Jul 29, 2024
Strides Pharma Science's revenue stood at Rs 1,087 crore in the period under review compared to Rs 932 crore in the year-ago quarter, the pharma company said.
Thu, Jul 18, 2024
Mumbai-based Lupin has signed a license and supply agreement with Huons for the registration and marketing of Cyclosporine Ophthalmic Nanoemulsion (0.4mL single-use vial) in Mexico.
Fri, Sep 29, 2023
Aurobindo Pharma surged on Friday, trading in huge volumes, after sources told Zee Business that the company received approval to launch its Revlimid drug.
Wed, Sep 27, 2023
The FMCG and Pharma sectors outperformed, with investors adopting a defensive approach to navigate global challenges, said Vinod Nair, Head of Research at Geojit Financial Services.
Thu, Sep 21, 2023
Cipla shares remained under pressure on Thursday after the US drug regulator issued five observations about a New York-based facility of the company's wholly-owned subsidiary, InvaGen Pharmaceuticals.
Tue, Sep 12, 2023
Lupin shares surged to a 52-week high on Tuesday, surpassing a peak touched last week, after the drug maker's board announced a business transfer agreement worth Rs 750-850 crore with its subsidiary, Lupin Manufacturing Solutions.
Fri, Aug 11, 2023
Aurobindo Pharma is likely to report a 12.7 per cent year-on-year jump in consolidated net profit to Rs 586 crore for the quarter ended June 30, according to Zee Business research.
Divi's Labs is likely to report a 42.6 per cent year-on-year fall in consolidated net profit to Rs 403 crore for the quarter ended June 30, according to Zee Business research.
Fri, Jul 28, 2023
Dr Reddy's Laboratories (DRL) shares have scaled a series of record peaks in the past few days. This week, the pharmaceutical major reported a strong all-round quarterly performance, with a better-than-expected 18.2 per cent year-on-year increase in net profit to Rs 1,405 crore for the April-June period.
Tue, Jul 25, 2023
Dr Reddy's Labs is scheduled to report its financial results for the June quarter on July 26. Analysts expect DRLto stage a strong quarterly performance driven by growing demand and improving margin.
Thu, Jul 20, 2023
Favorite shares of market experts, Which stocks did veteran investors buy? In which stocks did veterans increase their stake?
Dr Reddy's Labs shares scaled a 52-week high on Thursday after the drug maker said the US regulator completed an inspection at its Srikakulam API facility without any observation.
Wed, Jun 07, 2023
Zee Business brings to you 3 pharma stocks recommended by brokerage firms to keep an eye out for.
Wed, May 31, 2023
Torrent Pharma shares surged to a 52-week high on Wednesday, a day after the drug maker reported a quarterly net profit as against a net loss for the corresponding period a year ago.
Tue, May 30, 2023
AstraZeneca Pharma dividend: AstraZeneca Pharma India's board on Tuesday announced a dividend of Rs 16 per equity share for the financial year 2022-23.
Fri, May 19, 2023
Gland Pharma share price NSE, Gland Pharma share price target: Gland Pharma shares plunged on Friday 20, a day after the Hyderabad-based generic injectable manufacturer reported a weak set of financial results for the quarter ended March 2023.
Tue, May 16, 2023
Granules India Q4 results, dividend news: Granules India — a Hyderabad-based pharma company that makes Paracetamol and Ibuprofen — reported a net profit of Rs 119.6 crore for the quarter ended March 2023, missing analysts' estimates. Granules India's board recommended a dividend of 150 per cent.
Mon, May 15, 2023
Granules India Q4 results preview: Granules India, which manufactures painkiller drug Paracetamol and anti-inflammatory drug Ibuprofen, will report its Q4 results on May 16. Will Granules India also announce a dividend?
Mon, Apr 24, 2023
Why are Sun Pharma shares under pressure today? Sun Pharma declined due to which news? How much will be the impact on Sun Pharma? Know the complete details from Nupur in this video.
Tue, Mar 28, 2023
Pharma stocks were a mixed bag on Tuesday, as Sun Pharma, Lupin, Biocon, Aurobindo Pharma, Pfizer, Granules and Glaxosmith succumbed to selling pressure, and Cipla, Natco Pharma, Glenmark, Dr Reddy, Abbott India and Ipca Labs managed to eke out gains. Drug pricing regulator NPPA fixed retail prices of 25 formulations.
Mon, Mar 27, 2023
Lupin shares surged on Friday after the pharmaceutical major received nod from the US Food and Drug Administration (FDA) for valbenazine capsules, used in the treatment of adults with tardive dyskinesia, a medical condition that affects a person's movement and facial tics like lip-smacking and grimacing.
Tue, Mar 14, 2023
Lupin, Sun Pharma share price: Wild swings in the Indian share market come in the backdrop of sharp falls in the global markets owing to weakness in the banking space, after the collapse of US-based startup lender Silicon Valley Bank following a failed attempt to raise capital.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
